### 25866 Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices

Oostdyk, both of Plymouth, Minnesota; Justin Gabrielse, Maple Grove, Minnesota; Jayne Locascio, Palos Park, Illinois; William Oostdyk, South Elgin, Illinois; Valerie Therrien, Minneapolis, Minnesota; Katie Nelson, Frostburg, Maryland; and Keith Gabrielse, Cottage Grove, Wisconsin; together as a group acting in concert, to retain voting shares of Oak Financial, Inc., and thereby indirectly retain voting shares of Oak Bank, both in Fitchburg, Wisconsin.

B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001:

1. Tommy D. Craighead, Norman, Oklahoma, as trustee of the TCC & BJC Trusts No. 1 through 7, Ardmore, Oklahoma; to acquire voting shares of Citizens Commerce Corporation, and thereby indirectly acquire voting shares of Citizens Bank & Trust Company of Ardmore, both in Ardmore, Oklahoma.

Board of Governors of the Federal Reserve System, May 1, 2014.
Michael J. Lewandowski, Associate Secretary of the Board.

[FR Doc. 2014–10323 Filed 5–5–14; 8:45 am]

**BILLING CODE 6210–01–P**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Notice of Meeting**

**AGENCY :**  Agency for Healthcare Research and Quality, HHS.

**ACTION :**  Notice.

**SUMMARY :**  In accordance with section 10 (a) (2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) meeting on ‘‘AHRQ RFA–HS14–005, Patient Safety Learning Laboratories; Applying Design Innovation and Systems Engineering (P30)’’. Each SEP meeting will commence in open session before closing to the public for the duration of the meeting.

**DATES :**  May 29, 2014 ( Open on May 29 from 8:00 a.m. to 8:30 a.m. and closed for the remainder of the meeting ).

**ADDRESSES :**  Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, Maryland 20878.

**FOR FURTHER INFORMATION CONTACT :**  Anyone wishing to obtain a roster ofmembers, agenda or minutes of the nonconfidential portions of this meeting should contact: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone: (301) 427–

1554.

Agenda items for this meeting are subject to change as priorities dictate.

**SUPPLEMENTARY INFORMATION :**  A Special Emphasis Panel is a group of experts in
fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members ofthe Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Each SEP meeting will commence in open session before closing to the public for the duration of the meeting. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘AHRQ RFA–HS14–005, Patient Safety Learning Laboratories: Applying Design Innovation and Systems Engineering (P30)’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Dated: April 25, 2014.

Richard Kronick,

AHRQ Director.

[FR Doc. 2014–10277 Filed 5–5–14; 8:45 am]

**BILLING CODE 4160–90–P**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Patient Safety Organizations: Voluntary Relinquishment From**  **Medical Peer Review Resource, LLC**

**AGENCY :**  Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS).

**ACTION :**  Notice of Delisting. **SUMMARY :**  The Patient Safety and Quality Improvement Act of 2005, 42 U.S.C. 299b–21 to b-26, (Patient Safety Act) and the related Patient Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient Safety Rule), published in the Federal Register on November 21, 2008, 73 FR 70732– 70814, provide for the formation of Patient Safety Organizations (PSOs), which collect, aggregate, and analyze confidential information regarding the quality and safety of healthcare delivery. The Patient Safety Rule authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. AHRQ has accepted a notification of voluntary relinquishment from Medical Peer Review Resource, LLC of its status as a PSO, and has delisted the PSO accordingly. Medical Peer Review Resource, LLC submitted this request for voluntary relinquishment during revocation proceedings for cause.

**DATES :**  The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12:00 Midnight ET (2400) on April 2, 2014.

**ADDRESSES :**  Both directories can be accessed electronically at the following
HHS Web site: http:// www.pso.AHRQ.gov/index.html.

**FOR FURTHER INFORMATION CONTACT :**  Eileen Hogan, Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@AHRQ.hhs.gov.

**SUPPLEMENTARY INFORMATION :** 
Background

The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery.

HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an


### 25867 Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices

entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs.

AHRQ has accepted a notification from Medical Peer Review Resource, LLC, PSO number P0026, to voluntarily relinquish its status as a PSO. Accordingly, Medical Peer Review Resource, LLC was delisted effective at 12:00 Midnight ET (2400) on April 2, 2014. Medical Peer Review Resource, LLC, submitted this request for voluntary relinquishment during revocation proceedings for cause.

Medical Peer Review Resource, LLC has patient safety work product (PSWP) in its possession. The PSO will meet the requirements of section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO. In addition, according to sections 3.108(c)(2)(ii) and 3.108(b)(3) of the Patient Safety Rule regarding disposition of PSWP, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession.

More information on PSOs can be obtained through AHRQ’s PSO Web site

at http://www.pso.AHRQ.gov/
index.html.

Dated: April 25, 2014.
Richard Kronick,

AHRQ Director.

[FR Doc. 2014–10279 Filed 5–5–14; 8:45 am]

**BILLING CODE 4160–90–P**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Centers for Disease Control and**
**Prevention**

**Statement of Organization, Functions, and Delegations of Authority** 

Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 79 FR 21760–21763, dated April 17, 2014) is amended to
establish the World Trade Center Health Program, National Institute for Occupational Safety and Health, Centers
for Disease Control and Prevention.

Section C–B, Organization and Functions, is hereby amended as
follows:

After the title and functional
statement for the Division of Compensation Analysis and Support (CCN), National Institute for Occupational Safety and Health (CC), insert the following:

World Trade Center Health Program (CCP). (1) Provides the leadership and management to comply with the responsibilities under the James Zadroga 9/11 Act of 2010; Title) (XXIII of the Public Health Service Act; (2)
administers the World Trade Center Health Program (WTCHP); (3) develops, implements, and maintains a WTCHP quality assurance program; (4) provides annual reports to Congress; (5) consults with stakeholders in carrying out the WTCHP mission; (6) establishes and
administers a WTCHP Scientific Technical Advisory Committee; (7) develops and implements an education and outreach program; (8) provides for
uniform data collection and for data integration; (9) provides for
collaboration between Data Centers and World Trade Center (WTC) Health Registry; (10) enters into and oversees
contracts for Clinical Centers of Excellence, Data Centers, and Nationwide Provider Networks; (11) enters into agreement with New York City for purposes of collecting 10% of the specified funds stated in the Zadroga 9/11 Act of 2010; (12) ensures continuity of care; (13) reimburses
Clinical Centers of Excellence for infrastructure costs; (14) establishes a process for enrollment of WTC responders, and Pentagon and Shanksville responders; (15) conducts reviews to determine if cancer/types of
cancer should be added to list of WTCrelated health conditions; (16) issues regulations for medical necessity; (17)
reimburses costs for initial health evaluation, monitoring, and treatment; (18) establishes a process to determine and certify screening-eligible WTC survivors as certified-eligible survivors; (19) administers/collects recoupments from private insurance and workers compensation; (20) conducts and/or supports research; (21) ensures that a Registry of 9/11 victims is maintained; (22) enters into agreement(s) with the
Centers for Medicare and Medicaid Services for provider reimbursements; and (23) ensures compliance with all Health Insurance Portability and Accountability Act of 1996 (HIPAA) Public Law 104–191, statutory and regulatory provisions that govern the WTCHP as a covered entity, as well as any HHS HIPAA policies through the
establishment of a WTCHP HIPAA Compliance Program.

Dated: April 28, 2014. Sherri A. Berger, MSPH, Chief Operating Officer, Centers for
Disease Control and Prevention.

[FR Doc. 2014–10179 Filed 5–5–14; 8:45 am]

**BILLING CODE 4160–18–M**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Centers for Disease Control and**
**Prevention**

**Statement of Organization, Functions, and Delegations of Authority** 

Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 79 FR 21760–21763, dated April 17, 2014) is amended to reflect the reorganization of the Human Capital and Resource Management Office, Office of the Chief Operating Officer, Centers for Disease Control and

Prevention.

Section C–B, Organization and Functions, is hereby amended as
follows:

Delete in its entirety the title and the
mission and function statements for the Human Capital and Resource Management Office (CAJQ) and insert the following:

Human Resources Office (CAJQ). (1) Provides leadership, policy formation, oversight, guidance, service, and advisory support and assistance to the
Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR); (2) collaborates as appropriate, with the CDC Office of the Director (OD), Centers/Institute/Offices (CIOs), domestic and international agencies and organizations; and provides a focus for short-and long-term planning within the Human Resource Office (HRO); (3) develops and administers human capital and human resource management policies; (4)
serves as the business steward for all CDC developed human capital and human resources management systems and applications; (5) develops, maintains, and human resources management systems and applications; (5) develops, maintains, and supports information systems to conduct